Kailos Genetics, Inc.
New Filing
CIK: 0001503871·Biotechnology·DELAWARE·Filed: Apr 17, 2018
Total Offering
$2,000,000
Amount Sold
$1,975,000
Investors
8
First Sale
Feb 28, 2018
Offering Details
- Type
- Debt, Option to Acquire, Security to be Acquired, Other: Convertible debentures and preferred stock issuable upon conversion of convertible debentures
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Brian K. Pollock | Related Person |
| David Troy Moore | Related Person |
| Katherine T. Varley | Related Person |
| Michael J. Walters | Related Person |
| Randall C Bachmeyer | Related Person |
| James R Hudson, Jr. | Related Person |
| Danny Windham | Related Person |
| Cheri Walker | Related Person |
Company
SEC Filing
0001503871-18-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free